Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting-Reference-Cited by-同舟云学术

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

Published:2021-07 Issue:11 Volume:81 Page:1331-1342
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Shirley Matt

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-021-01558-2.pdf

Reference47 articles.

1. Adel N. Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies. Am J Manag Care. 2017;23(14 Suppl):S259–65.

2. Herrstedt J, Roila F, Warr D, et al. 2016 Updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy. Support Care Cancer. 2017;25(1):277–88.

3. Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: ASCO guideline update. J Clin Oncol. 2020;38(24):2782–97.

4. National Comprehensive Cancer Network. NCCN Clinical Practice Guildelines in Oncology (NCCN Guidelines®): antiemesis (version 1.2021). 2020. https://www.nccn.org. Accessed 24 May 2021.

5. Roila F, Warr D, Hesketh PJ, et al. 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following moderately emetogenic chemotherapy. Support Care Cancer. 2017;25(1):289–94.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economical and rapid enantioselective, diastereoselective and achiral separation of palonosetron hydrochloride and its impurities using supercritical fluid chromatography;Journal of Chromatography A;2024-11

2. Adequate antiemetic treatment in patients receiving antitumor drug therapy;Head and Neck Tumors (HNT);2024-08-03

3. Safety assessment of neurokinin-1 receptor antagonist: real-world adverse event analysis from the FAERS database;Frontiers in Pharmacology;2024-07-31

4. Real hopes in antiemetic therapy;Meditsinskiy sovet = Medical Council;2024-07-25

5. Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis;Clinical Breast Cancer;2024-07